Detection system and uses therefor

• US 8,283,127 B2
• Filed: 11/09/2007
• Issued: 10/09/2012
• Est. Priority Date: 11/10/2006
• Status: Active Grant

• Current Assignee: Dimerix Bioscience Pty Ltd. (Dimerix Ltd.)
• Original Assignee: Dimerix Bioscience Pty Ltd. (Dimerix Ltd.)
• Inventors: See, Heng Boon, Pfleger, Kevin D., Seeber, Ruth M., Eidne, Karin A.
• Primary Examiner(s): Cook, Lisa
• Application Number:
  US12/442,899
• Publication Number:
  US 20100021457A1
• Time in Patent Office: 1,796 Days
• Field of Search: None
• US Class Current: 435/7.21
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 25/08 Antiepileptics; Anticonvulsants
• CPC Class Codes: A61P 25/16 Anti-Parkinson drugs
• CPC Class Codes: A61P 25/18 Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• CPC Class Codes: A61P 25/22 Anxiolytics
• CPC Class Codes: A61P 25/24 Antidepressants
• CPC Class Codes: A61P 25/28 for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching

Abstract

A system for the detection of molecular associations, the system comprising: i) a first agent, comprising a first interacting group coupled to a first reporter component; ii) a second agent, comprising a second interacting group coupled to a second reporter component; iii) a third agent, comprising a third interacting group; iv) a modulator; and v) a detector; wherein proximity of the first and second reporter components generates a signal capable of detection by the detector; and wherein the modulator modulates the association of the second interacting group with the third interacting group; such that monitoring the signal generated by proximity of the first and second reporter components by the detector constitutes monitoring the association of the first and third agents.

Claims

1. A method for determining whether and/or the extent to which a test compound interacts with a second protein when the second protein is associated with a first protein, the method comprising the steps of:

a) contacting said test compound with a system comprising;

i) a first agent, comprising the first protein coupled to a first reporter component;

ii) a second agent, comprising an interacting group coupled to a second reporter component; and

iii) a third agent, comprising the second protein;

wherein proximity of the first and second reporter components generates a signal; and

wherein a modulator modulates the association of the interacting group with the second protein; and

b) determining the signal as a determination of whether and/or the extent to which said test compound interacts with a second protein when the second protein is associated with the first protein.

2. The method according to claim 1 characterised in that the second protein is a receptor, such that the method for determining whether and/or the extent to which a test compound interacts with the second protein when the second protein is associated with the first protein comprises a method for determining whether and/or the extent to which the test compound is an agonist of the second protein when the second protein is associated with the first protein, and the step of determining the signal as a determination of whether and/or the extent to which said test compound interacts with the second protein when the second protein is associated with the first protein more specifically comprises the step of detecting an increase in the signal as a determination of whether the test compound is an agonist of the second protein when the second protein is associated with the first protein.

3. The method according to claim 2 characterised in that the first protein is a receptor.

4. The method according to claim 1 characterised in that the second protein is a receptor, such that the method for determining whether and/or the extent to which a test compound interacts with the second protein when the second protein is associated with the first protein comprises a method for determining whether and/or the extent to which the test compound is an antagonist or partial agonist of the second protein when the second protein is associated with the first protein, the method comprising the steps of:

a) contacting said test compound with the system comprising;

i) the first agent, comprising the first protein coupled to the first reporter component;

ii) the second agent, comprising the interacting group coupled to the second reporter component;

iii) the third agent, comprising the second protein; and

iv) an agonist of the second protein;

 

wherein proximity of the first and second reporter components generates the signal; and

wherein the modulator modulates the association of the interacting group with the second protein; and

b) detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an antagonist or partial agonist of the second protein when the second protein is associated with the first protein.

5. The method according to claim 4 characterised in that the first protein is a receptor.

6. The method according to claim 1 characterised in that the second protein is a constitutively active receptor, such that the method for determining whether and/or the extent to which the test compound interacts with the second protein when the second protein is associated with the first protein comprises a method for determining whether and/or the extent to which the test compound is an inverse agonist of the second protein when the second protein is associated with the first protein, and the step of determining the signal as a determination of whether and/or the extent to which said test compound interacts with the second protein when the second protein is associated with the first protein more specifically comprises the step of detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an inverse agonist of the second protein when the second protein is associated with the first protein.

7. The method according to claim 6 characterised in that the first protein is a receptor.

8. The method according to claim 1 characterised in that, the first and second proteins are both receptors, such that the method for determining whether and/or the extent to which the test compound interacts with the second protein when the second protein is associated with the first protein comprises a method for screening the compound for first protein/second protein hetero-dimer/-oligomer selective activity, the method comprising the steps of:

a) determining whether, and/or the extent to which, the test compound interacts with the second protein while the second protein is associated with the first protein; and

b) if the test compound interacts with the second protein while the second protein is associated with the first protein, determining whether, and/or the extent to which the test compound interacts with the second protein in the absence of the first protein;

such that the test compound that exhibits greater affinity and/or potency and/or efficacy when interacting with the second protein while the second protein is associated with the first protein is selective for the first protein/second protein hetero-dimer/-oligomer.

9. The method according to claim 1 characterised in that the first and second proteins are both receptors, and the method comprises a method for screening the test compound for first protein/second protein hetero-dimer/-oligomer selective antagonism or partial agonism, the method comprising the steps of:

a) determining whether, and/or the extent to which, the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer, by contacting said test compound with a system comprising;

i) the first agent, comprising the first protein coupled to the first reporter component;

ii) the second agent, comprising an interacting group coupled to the second reporter component;

iii) the third agent, comprising the second protein; and

iv) an agonist of the first protein, the second protein and/or the first protein/second protein hetero-dimer/-oligomer,

wherein proximity of the first and second reporter components generates the signal; and

wherein the modulator modulates the association of the interacting group with the second protein;

b) detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer; and

c) if the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer, determining whether, and/or the extent to which the test compound interacts with the second protein in the absence of the first protein and the first protein in the absence of the second protein;

such that the test compound that exhibits greater antagonistic or partial agonistic properties when interacting with the first protein/second protein hetero-dimer/-oligomer is selective for the first protein/second protein hetero-dimer/-oligomer.

11. The method according to claim 1 characterised in that the first and second proteins are both receptors, and the method comprises a method for screening a test compound for first protein/second protein hetero-dimer/-oligomer selective inverse agonism, the method comprising the steps of:

a) determining whether, and/or the extent to which, the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer, by contacting said test compound with a system comprising;

i) the first agent, comprising the first protein coupled to the first reporter component;

ii) the second agent, comprising the interacting group coupled to the second reporter component; and

iii) the third agent, comprising the second protein, wherein the second protein is constitutively active, and

wherein proximity of the first and second reporter components generates the signal; and

wherein the modulator modulates the association of the interacting group with the second protein;

b) detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer; and

c) if the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer, determining whether, and/or the extent to which the test compound is an inverse agonist of the first protein in the absence of the second protein and the second protein in the absence of the first protein;

such that a test compound that exhibits greater inverse agonistic properties when interacting with the first protein/second protein hetero-dimer/-oligomer is selective for the first protein/second protein hetero-dimer/-oligomer.

10. A method for determining whether and/or the extent to which a test compound interacts with a second protein when the second protein is associated with a first protein, the method characterised in that the first and second proteins are both receptors, and the method comprises a method for screening a test compound for first protein/second protein hetero-dimer/-oligomer selective antagonism or partial agonism, the method comprising the steps of:

a) determining whether, and/or the extent to which, the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer, by contacting said test compound with a system comprising;

i) a first agent, comprising the second protein coupled to a first reporter component;

ii) a second agent, comprising an interacting group coupled to a second reporter component;

iii) a third agent, comprising the first protein;

iv) an agonist of the second protein, the first protein and/or the first protein/second protein hetero-dimer/-oligomer,

wherein proximity of the first and second reporter components generates a signal, and wherein a modulator modulates association of the interacting group with the first protein;

b) detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer; and

c) if the test compound is an antagonist or partial agonist of the first protein/second protein hetero-dimer/-oligomer, determining whether, and/or the extent to which the test compound is an antagonist or partial agonist of the first protein in the absence of the second protein and the second protein in the absence of the first protein;

such that a test compound that exhibits greater antagonistic or partial agonistic properties when interacting with the first protein/second protein hetero-dimer/-oligomer is selective for the first protein/second protein hetero-dimer/-oligomer.

12. A method for determining whether and/or the extent to which a test compound interacts with a second protein when the second protein is associated with a first protein, the method characterised in that the first and second proteins are both receptors, and the method comprises a method for screening a test compound for first protein/second protein hetero-dimer/-oligomer selective inverse agonism, the method comprising the steps of:

a) determining whether, and/or the extent to which, the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer, by contacting said test compound with a system comprising;

i) a first agent, comprising the second protein coupled to a first reporter component;

ii) a second agent, comprising an interacting group coupled to a second reporter component;

iii) a third agent, comprising the first protein, wherein the first protein is constitutively active, and wherein proximity of the first and second reporter components generates a signal, and wherein a modulator modulates association of the interacting group with the first protein;

b) detecting a decrease in the signal as a determination of whether and/or the extent to which the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer; and

c) if the test compound is an inverse agonist of the first protein/second protein hetero-dimer/-oligomer, determining whether, and/or the extent to which the test compound is an inverse agonist of the second protein in the absence of the first protein and the first protein in the absence of the second protein;

such that the test compound that exhibits greater inverse agonistic properties when interacting with the first protein/second protein hetero-dimer/-oligomer is selective for the first protein/second protein hetero-dimer/-oligomer.